Lumbar Disc Herniation
Conditions
Interventions
Traditional Chinese Medicine Group:Yiqi Huoxue Formula
Control Group:Steroidal/Non-Steroidal Anti-Inflammatory Drugs
Sponsors
Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) First-visit diagnosis of LDH confirmed by MRI. (2) Non-surgical treatment selected as the initial therapeutic approach. (3) Age 18–65 years, regardless of sex. (4) Voluntarily participate in the study and sign the written informed consent.
Exclusion criteria
Exclusion criteria: (1) Severe primary cardiovascular, cerebrovascular, hepatic, renal, hematological diseases, or psychiatric disorders. (2) Pregnancy or lactation. (3) History of lumbar spine surgery or any prior intraspinal injection therapy. (4) Spinal deformities or major spinal diseases, including scoliosis, spinal tumors, or inflammatory spinal diseases. (5) Severe degenerative spinal diseases such as significant lumbar spinal stenosis, advanced osteoarthritis, disc cysts, subchondral cysts, or ganglion cysts. (6) Other lumbar conditions that may significantly influence prognosis, including lumbar spondylolisthesis or isthmic defects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| absorption rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analog Scale;Oswestry Disability Index;Japanese Orthopaedic Association score; | — |
Countries
China
Contacts
Public ContactYu Pengfei
Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine
Outcome results
None listed